UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO
SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): May 5, 2003
COMMISSION FILE NUMBER 333-92383
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
(Exact Name of Registrant as specified in its Charter)
DELAWARE |
|
06-1397316 |
|
(State of Incorporation) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
251 BALLARDVALE STREET, WILMINGTON, MASSACHUSETTS 01887 |
||
|
(Address of Principal Executive Offices) (Zip Code) |
||
|
|
|
|
|
978-658-6000 |
||
|
(Registrant’s Telephone Number, Including Area Code) |
||
ITEM 9. REGULATION FD DISCLOSURE
On May 5, 2003, Charles River Laboratories, Inc., wholly-owned subsidiary of the Registrant, posted to its company website an updated investor presentation, a copy of which is filed herewith as Exhibit 99.1.
EXHIBIT 99.1
Investor Presentation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
|||
|
|
|
|||
|
Dated: May 5, 2003 |
|
|||
|
|
|
|||
|
|
By: |
/s/ Dennis R. Shaughnessy |
|
|
|
|
|
|||
|
|
Dennis R. Shaughnessy, Sr. Vice President, |
|||
|
|
Corporate Development, General Counsel |
|||
|
|
and Secretary |
|||
2